Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
20.98
Dollar change
-0.81
Percentage change
-3.72
%
IndexRUT P/E- EPS (ttm)-0.91 Insider Own0.68% Shs Outstand164.18M Perf Week-7.17%
Market Cap3.44B Forward P/E22.59 EPS next Y0.93 Insider Trans-19.54% Shs Float163.06M Perf Month-9.53%
Income-148.81M PEG- EPS next Q0.31 Inst Own96.34% Short Float / Ratio4.78% / 4.83 Perf Quarter-22.67%
Sales631.89M P/S5.45 EPS this Y75.01% Inst Trans0.88% Short Interest7.79M Perf Half Y-15.13%
Book/sh2.21 P/B9.50 EPS next Y377.38% ROA-24.10% Target Price32.75 Perf Year43.11%
Cash/sh2.11 P/C9.96 EPS next 5Y- ROE-37.78% 52W Range14.45 - 33.99 Perf YTD31.78%
Dividend- P/FCF- EPS past 5Y10.76% ROI-36.27% 52W High-38.28% Beta0.52
Dividend %- Quick Ratio2.28 Sales past 5Y35.48% Gross Margin95.86% 52W Low45.19% ATR0.79
Employees513 Current Ratio2.38 Sales Q/Q61.96% Oper. Margin-24.43% RSI (14)38.34 Volatility3.76% 3.15%
OptionableYes Debt/Eq0.16 EPS Q/Q-136.33% Profit Margin-23.55% Rel Volume0.89 Prev Close21.79
ShortableYes LT Debt/Eq0.13 EarningsNov 02 AMC Payout- Avg Volume1.61M Price20.98
Recom1.89 SMA20-6.06% SMA50-6.66% SMA200-10.74% Volume1,440,135 Change-3.72%
Date Action Analyst Rating Change Price Target Change
Nov-06-23Upgrade Mizuho Neutral → Buy $20 → $35
Oct-17-23Initiated UBS Buy $33
Oct-10-23Upgrade JP Morgan Neutral → Overweight $29 → $32
Jan-03-23Upgrade Guggenheim Neutral → Buy $22
Nov-04-22Downgrade Goldman Neutral → Sell $15 → $12
Nov-01-22Initiated Loop Capital Hold $17
Aug-08-22Downgrade Citigroup Buy → Neutral $19 → $15
Aug-05-22Downgrade Citigroup Buy → Neutral $19 → $15
Jun-21-22Downgrade Jefferies Buy → Underperform $25 → $10
Jun-16-22Upgrade Jefferies Hold → Buy $25
Nov-30-23 09:05AM
Nov-27-23 09:05AM
Nov-21-23 11:03PM
05:00PM
Nov-17-23 09:40AM
08:42AM Loading…
Nov-16-23 08:42AM
Nov-14-23 04:12PM
Nov-08-23 05:24PM
Nov-04-23 01:10PM
Nov-02-23 06:51PM
04:37PM
04:05PM
Oct-31-23 04:05PM
Oct-26-23 10:02AM
Oct-23-23 09:05AM
04:05PM Loading…
Oct-19-23 04:05PM
Oct-18-23 05:00PM
Oct-10-23 10:49AM
09:32AM
Oct-07-23 05:01AM
Sep-30-23 10:30AM
Sep-22-23 06:23PM
Sep-19-23 04:05PM
Aug-30-23 04:05PM
Aug-28-23 06:00PM
Aug-22-23 08:30AM
Aug-19-23 10:44AM
Aug-14-23 04:05PM
Aug-04-23 12:36PM
Aug-02-23 04:26PM
04:05PM Loading…
04:05PM
Aug-01-23 07:30PM
Jul-25-23 11:21AM
Jul-24-23 04:05PM
Jul-21-23 09:40AM
Jul-19-23 04:04PM
Jul-15-23 08:19AM
Jul-14-23 04:04PM
11:41AM
Jul-13-23 07:11PM
04:05PM
Jun-26-23 05:00PM
Jun-13-23 04:05PM
Jun-12-23 01:24PM
Jun-08-23 11:10AM
Jun-07-23 11:30AM
05:58AM
Jun-01-23 09:04AM
May-08-23 05:25PM
04:13PM
04:05PM
09:21AM
May-05-23 04:04PM
May-02-23 09:04AM
Apr-25-23 09:04AM
Apr-20-23 09:04AM
Apr-17-23 09:04AM
Apr-11-23 09:04AM
07:44AM
Mar-13-23 12:56PM
12:11PM
Mar-10-23 09:45PM
Mar-07-23 09:45AM
Mar-02-23 05:45AM
Mar-01-23 05:41AM
Feb-28-23 04:00PM
09:26AM
Feb-27-23 05:25PM
04:05PM
Feb-20-23 10:00AM
Feb-14-23 04:05PM
Feb-13-23 04:15PM
Jan-09-23 09:00AM
Jan-03-23 11:58AM
09:00AM
08:28AM
Dec-21-22 04:05PM
Nov-08-22 04:05PM
Nov-03-22 12:23PM
Nov-02-22 05:35PM
04:05PM
Nov-01-22 10:04AM
Oct-27-22 04:05PM
10:02AM
Oct-26-22 10:02AM
09:11AM
Oct-20-22 04:05PM
Oct-19-22 12:02PM
Oct-13-22 07:30AM
Oct-12-22 10:57AM
Oct-06-22 01:36PM
Oct-04-22 02:19PM
07:30AM
Sep-13-22 08:44AM
Sep-12-22 07:30AM
Sep-07-22 11:30AM
Sep-01-22 09:03AM
Aug-30-22 09:55AM
Aug-26-22 12:00PM
Aug-09-22 01:24PM
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schneyer Mark C.EVP, Chief Financial OfficerNov 20Sale22.645,108115,64520,486Nov 21 06:00 PM
Teehan BrendanEVP, COO, Head of CommercialNov 20Sale22.644,960112,29430,393Nov 21 06:00 PM
Kihara JamesPrincipal Accounting OfficerNov 20Sale22.641,98544,94013,025Nov 21 06:00 PM
DAVIS STEPHENCEOOct 06Sale21.9651,5631,132,32389,131Oct 06 09:59 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryOct 06Sale21.9616,369359,46345,857Oct 06 10:00 PM
Kihara JamesPrincipal Accounting OfficerSep 15Sale25.882,00051,76010,778Sep 19 06:31 PM
Schneyer Mark C.EVP, Chief Financial OfficerAug 21Sale29.0010,000289,97015,682Aug 23 07:31 PM
DAVIS STEPHENCEOJul 14Option Exercise20.77100,0002,077,000136,695Jul 18 06:00 PM
DAVIS STEPHENCEOJul 14Sale30.04100,0003,004,35036,695Jul 18 06:00 PM
DAVIS STEPHENCEOJul 12Sale25.0555,1041,380,44936,695Jul 13 08:27 PM
DAVIS STEPHENCEOJul 11Sale25.0016,498412,45091,799Jul 13 08:27 PM
Kihara JamesPrincipal Accounting OfficerJun 15Sale24.152,00048,3009,144Jun 16 04:38 PM
Brege LauraDirectorJun 12Sale24.874,500111,90613,502Jun 14 05:14 PM
Schneyer Mark C.EVP, Chief Financial OfficerJun 08Option Exercise0.001,893023,798Jun 12 08:48 PM
Schneyer Mark C.EVP, Chief Financial OfficerJun 08Sale25.0297424,36922,824Jun 12 08:48 PM
BAKER BROS. ADVISORS LPDirectorMay 24Buy25.48553,26314,096,82539,317,673May 24 05:09 PM
BAKER BROS. ADVISORS LPDirectorMay 23Option Exercise17.0125,000425,25038,620,261May 24 05:09 PM
BAKER BROS. ADVISORS LPDirectorMay 23Buy25.41209,0535,312,45838,811,515May 24 05:09 PM
BAKER BROS. ADVISORS LPDirectorMay 22Buy24.57134,2063,297,81538,607,761May 24 05:09 PM
Schneyer Mark C.EVP, Chief Financial OfficerMay 17Sale22.5015,310344,47521,905May 19 06:48 PM
Teehan BrendanEVP, COO, Head of CommercialMay 17Sale22.5014,869334,55224,356May 19 06:43 PM
Kihara JamesPrincipal Accounting OfficerMay 17Sale22.505,947133,80811,144May 19 06:54 PM
DAVIS STEPHENCEOMay 01Sale21.187,806165,331108,297May 02 07:02 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryMay 01Sale21.1891719,42225,513May 02 07:06 PM
Teehan BrendanEVP, COO, Head of CommercialMay 01Sale21.1854811,6079,487May 02 07:04 PM
Teehan BrendanEVP, COO, Head of CommercialApr 29Option Exercise0.001,567010,035May 02 07:04 PM
DAVIS STEPHENCEOApr 29Option Exercise0.0015,6250116,103May 02 07:02 PM
Kihara JamesPrincipal Accounting OfficerApr 10Sale18.145239,4875,197Apr 11 09:15 PM
DAVIS STEPHENCEOApr 06Sale18.168,582155,849100,478Apr 07 08:34 PM
Schneyer Mark C.EVP, Chief Financial OfficerApr 06Sale18.161,91634,7957,477Apr 07 08:37 PM
Teehan BrendanEVP, COO, Head of CommercialApr 06Sale18.161,75131,7988,468Apr 07 08:44 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryApr 06Sale18.161,45626,44123,425Apr 07 08:32 PM
Kihara JamesPrincipal Accounting OfficerApr 06Sale18.1670112,7304,231Apr 07 08:41 PM
DAVIS STEPHENCEOFeb 24Sale18.783,85172,32291,727Feb 27 09:00 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryFeb 24Sale18.7880315,08020,108Feb 27 09:00 PM
Schneyer Mark C.EVP, Chief Financial OfficerFeb 24Sale18.7857710,8364,118Feb 27 09:00 PM
Teehan BrendanEVP, COO, Head of CommercialFeb 24Sale18.784618,6585,195Feb 27 09:00 PM
Kihara JamesPrincipal Accounting OfficerFeb 24Sale18.783506,5732,923Feb 27 09:00 PM
Brege LauraDirectorJan 12Option Exercise17.0112,500212,62512,500Jan 17 05:17 PM
BAKER BROS. ADVISORS LPDirectorJan 12Option Exercise5.2230,000156,60038,484,981Jan 17 04:22 PM
Brege LauraDirectorJan 12Sale18.2512,500228,1250Jan 17 05:17 PM
DAVIS STEPHENCEOJan 09Sale17.133,90466,87784,633Jan 10 08:38 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryJan 09Sale17.1358910,09018,697Jan 10 08:20 PM
Teehan BrendanEVP, COO, Head of CommercialJan 09Sale17.135329,1134,549Jan 10 08:30 PM